| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/30/2004 | WO2004060351A3 Pharmaceutical formulation with an insoluble active agent for pulmonary administration |
| 09/30/2004 | WO2004058769A3 Triazolopyridazines as protein kinases inhibitors |
| 09/30/2004 | WO2004058268A3 Use of von tetrahydrobiopterine derivatives in the treatment and nutrition of patients with amino acid metabolic disorders |
| 09/30/2004 | WO2004058143A3 High specificity anticancer pharmacological drug system, drug synthesis, and drug development process |
| 09/30/2004 | WO2004058138A3 Oil composition based on peroxidised lipids, which can be used in the treatment of xerostomia |
| 09/30/2004 | WO2004052308A3 Topical anti-infective formulations |
| 09/30/2004 | WO2004050689A3 Aza-peptides |
| 09/30/2004 | WO2004050084A3 Ace-inhibitors having antioxidant and nitricoxid-donor activity |
| 09/30/2004 | WO2004050058A3 Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base |
| 09/30/2004 | WO2004050022B1 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 09/30/2004 | WO2004047796A3 Pulverulent formulation for inhalation containing tiotropium |
| 09/30/2004 | WO2004047725A3 8-hydroxy-1-oxo-tetrahydropyrrolopyrazine compounds useful as hiv integrase inhibitors |
| 09/30/2004 | WO2004045618A3 Novel medicaments for the treatment of chronic obstructive pulmonary diseases |
| 09/30/2004 | WO2004045523A3 Combination administration of an indolinone with a chemotherapeutic agent for cell proliferation disorders |
| 09/30/2004 | WO2004044046A3 Combination products with carboxylic acid derivatives that inhibit the binding of integrins to their receptors and other therapeutic compounds |
| 09/30/2004 | WO2004043349A3 Isoxazoline derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme |
| 09/30/2004 | WO2004043331A3 Dermastick thickened ointment |
| 09/30/2004 | WO2004041209A3 Transcription factor modulating compounds and methods of use thereof |
| 09/30/2004 | WO2004037243A3 Methods of treatment during vascular procedures |
| 09/30/2004 | WO2004037180A3 Compositions that treat or inhibit pathological conditions associated with inflammatory response |
| 09/30/2004 | WO2004037164A3 Crosslinked compounds and methods of making and using thereof |
| 09/30/2004 | WO2004034992A3 Encapsulation and deaggregation of polyene antibiotics using poly(ethylene glycol)-phospholipid micelles |
| 09/30/2004 | WO2004033478A3 Fatty acid modified forms of glucocorticoids and their use as anti-inflammatory |
| 09/30/2004 | WO2004032854A3 Pharmaceutical compositions for treatment of parkinson's disease |
| 09/30/2004 | WO2004032849A3 Methods of administering fgf18 |
| 09/30/2004 | WO2004032716A3 Compounds for modulation of cholesterol transport |
| 09/30/2004 | WO2004030661A3 Therapeutic compositions comprising a boron-containing compound |
| 09/30/2004 | WO2004030519A3 Thymic atrophy |
| 09/30/2004 | WO2004028448A3 Method of alleviating pain via inhibition of neurotransmitter synthesis |
| 09/30/2004 | WO2004022059A3 Use of 6 amino-quinoline-5, 8 quinones and nucleic acids associated with senescence for the treatment of tumors |
| 09/30/2004 | WO2004016214A3 Methods and compositions for treatment of macular and retinal disease |
| 09/30/2004 | WO2003106629A3 Treating vitamin d responsive diseases |
| 09/30/2004 | WO2003103586A3 Method for treating autoimmune or inflammatory diseases with combinations of inhibitory oligonucleotides and small molecule antagonists of immunostimulatory cpg nucleic acids |
| 09/30/2004 | WO2003101383A3 Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment |
| 09/30/2004 | WO2003097806A3 Substituted 4-aryl-4h-pyrrolo[2,3-h]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 09/30/2004 | WO2003092583A3 Methods and compositions for treating ectoparasite infestation |
| 09/30/2004 | WO2003088903A3 Compounds, compositions, and methods |
| 09/30/2004 | WO2003080105A9 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof |
| 09/30/2004 | WO2003072535A8 Substituted hydroxyethylamines |
| 09/30/2004 | WO2003026623A8 Intraorally disintegrating valdecoxib compositions |
| 09/30/2004 | WO2003024396A3 Dry powder medicament formulations |
| 09/30/2004 | WO2003014075A3 Novel gamma secretase inhibitors |
| 09/30/2004 | US20040193159 Spinal implants, insertion instruments, and methods of use |
| 09/30/2004 | US20040192961 such as 2-nitrophenol by reacting 3-hydroxy-4-methoxybenzophenone with alkyl nitrate in presence of regioselective acid catalyst (sulfuric acid) |
| 09/30/2004 | US20040192944 14-Hydrido-9beta-hydroxytetracyclic taxanes |
| 09/30/2004 | US20040192943 Nf-kappab inhibitors |
| 09/30/2004 | US20040192928 Reduce skin sensitivity; dissolving 4,5-diphenylimidazole in aprotic solvent; mixing with base and alkyl halide; heating |
| 09/30/2004 | US20040192926 Substituted indolyl quinolinone compounds; angiogenesis inhibitors; antitumor agents; atherosclerosis; vision defects; antidiabetic agents; antiinflammatory agents |
| 09/30/2004 | US20040192922 Novel azole or triazole derivatives, method for preparing the same and use thereof as antifungal medicaments |
| 09/30/2004 | US20040192916 Analgesics; neuropathic pain; headaches; muscle relaxants; incontence; tinnitus; diarrhea; antiarrhythmia agents; antiischemic agents; antiinflammatory agents; antiulcer agents; antidepressants; antiepileptic agents |
| 09/30/2004 | US20040192914 Compounds and methods |
| 09/30/2004 | US20040192908 Human and veterinary medicine; drugs, cosmetics ; prevention therapy dyslipidemia; cardiovascular disorders; antidiabetic agents; obesity; hypotensive agents; antiaging agents; anticancer agents |
| 09/30/2004 | US20040192904 Process for the preparation of ribavirin |
| 09/30/2004 | US20040192786 Use of xylitol to reduce ionic strength and activate endogenous antimicrobials for prevention and treatment of infections |
| 09/30/2004 | US20040192785 Inhibition of TNF-alpha-initiated neutrophil response |
| 09/30/2004 | US20040192784 Synergistic mixture; containing hydroxy-3-methylglutaryl/3-/ coenzyme a inhibitor |
| 09/30/2004 | US20040192783 Use of B-2 bronchodilator drugs |
| 09/30/2004 | US20040192782 Erucamide compounds for the treatment and prevention to disturbances of the secretory system |
| 09/30/2004 | US20040192781 Method of administration for metoclopramide and pharmaceutical formulation therefor |
| 09/30/2004 | US20040192779 2-amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 09/30/2004 | US20040192776 Cationic lipid compositions targeting angiogenic endothelial cells |
| 09/30/2004 | US20040192774 Method for improving the well-being of poultry by in-ovo injection of carnitine |
| 09/30/2004 | US20040192773 Administering an benzene ester or amide compound |
| 09/30/2004 | US20040192772 Agent for treating the symptoms of dementia disorders and/or depression |
| 09/30/2004 | US20040192771 Cerdiovascular disorders; antilipemic agents; alzheimer's disease; anticancer agents; sepsis; thrombosis; hypotensive agents; kidney diseases; antiinflammatory agents |
| 09/30/2004 | US20040192768 Aqueous solution of ascorbic acid and method for producing same |
| 09/30/2004 | US20040192767 EP4 receptor antagonists |
| 09/30/2004 | US20040192766 Use of enantiomeric pure escitalopram |
| 09/30/2004 | US20040192765 Use of enantiomeric pure escitalopram |
| 09/30/2004 | US20040192764 Use of enantiomeric pure escitalopram |
| 09/30/2004 | US20040192763 Central nervous system disorders; antidepressants; neurodegenative diseases; restless leg syndrome; antiepileptic agents; headaches; hearing disorders |
| 09/30/2004 | US20040192762 Total synthesis of daurichromenic acid |
| 09/30/2004 | US20040192761 Preventative and treatment effects of morinda citrifolia as an aromatase inhibitor |
| 09/30/2004 | US20040192759 Use of nefiracetam for treating neurodegeneration |
| 09/30/2004 | US20040192757 Reacting a 2-pyrrolidinone with alpha-keto acid; cyclization, ammonolysis , catalytic hydrogenation |
| 09/30/2004 | US20040192756 Amino-acid-based compositions, suitable in therapy for the healing and/or mending of wounds and lesions, in particular for application in the opthalmic field |
| 09/30/2004 | US20040192755 Immediate release medicinal compositions for oral use |
| 09/30/2004 | US20040192754 Administering serotonin inhibitors; such as ketanserin, ritanserin, mainserin, cyproheptadine, fluoxetine, olanzapine, ziprasidone |
| 09/30/2004 | US20040192753 Methods of use of thrombin receptor antagonists |
| 09/30/2004 | US20040192752 Anti-HIV pyrazole derivatives |
| 09/30/2004 | US20040192751 Amino acid composition for ameliorating liver failure |
| 09/30/2004 | US20040192748 Heterocyclic compounds |
| 09/30/2004 | US20040192746 Anticancer agents; central nervous system disorders; sexual disorders; antidiabetic agents; obesity; muscular disorders; alopecia; sepsis; autoimmune disease |
| 09/30/2004 | US20040192745 Method of treating amytrophic lateral sclerosis using melatonin |
| 09/30/2004 | US20040192744 Inhibition of Histone Deacetylase; antiproliferative; antitumor: cell differentiation; 3,5-Dimethyl-isoxazole-4-carboxylic acid (2-amino-4,5-dichloro-phenyl)-amide |
| 09/30/2004 | US20040192743 Substituted azole derivatives as therapeutic agents |
| 09/30/2004 | US20040192742 Antiarthritic agents; muscular dystrophy; antiinflammatory agents; glomerulonephritis; malaria; oral diseases |
| 09/30/2004 | US20040192740 for treating or preventing conditions associated with altered mitochondrial function with such compounds eg Alzheimer's Disease; diabetes mellitus; obesity; Parkinson's Disease; Huntington's disease; dystonia; Leber's hereditary optic neuropathy |
| 09/30/2004 | US20040192739 Contacting a cell expressing the Edg-2 receptor with an amount of an modulator of the Edg-2 receptor sufficient to modulate the Edg-2 receptor mediated biological activity |
| 09/30/2004 | US20040192737 Use of thiazolidinediones for the treatment of hyperglycaemia |
| 09/30/2004 | US20040192736 New indoline compounds |
| 09/30/2004 | US20040192735 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 09/30/2004 | US20040192733 Hydroxamic acid derivatives |
| 09/30/2004 | US20040192732 Methods for treating substance abuse with cholinesterase inhibitors |
| 09/30/2004 | US20040192730 Synergistic mixtures; before sex |
| 09/30/2004 | US20040192729 Purification of antibodiees; elisa; neurotransmitter research; antidiabetic agents; skin disorders; antiinflammatory agents; antihistamines |
| 09/30/2004 | US20040192726 Farnesyl protein transferase inhibitors for treating breast cancer |
| 09/30/2004 | US20040192725 Tyrosine kinase inhibitors |
| 09/30/2004 | US20040192722 Selective iGluR5 receptor antagonists |
| 09/30/2004 | US20040192720 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators |